top of page
4 Companies with FDA Approval Decisions Expected Before the End of January 🗓️
We’re always excited to find bio/pharma companies nearing their therapeutic product launch! These 4 companies have FDA final approval decision (PDUFA) dates before the end of January: Atara Biotherapeutics (NASDAQ: ATRA ) Drug/Therapy: Tab-cel (tabelecleucel) Allogeneic T-cell immunotherapy Indication: Post-Transplant Lymphoproliferative Disease (PTLD) PDUFA date: January 15, 2025 BLA with priority review Biogen (NASDAQ: BIIB ) Drug/Therapy: Leqembi (Lecanemab) IV Maintenance
Jan 51 min read
4 Companies with FDA Approval Decisions Expected Before the End of January 🗓️
We’re always excited to find bio/pharma companies nearing their therapeutic product launch!
Jan 51 min read


How does Lecanemab compare to other Alzheimer's assets?
Summary: Biogen and Eisai's asset Lecanemab has a PDUFA date set for Friday 1/6/23 Lecanemab targets and effectively reduces beta-amyloid...
Jan 4, 20235 min read


Biopharma Daily Pulse - 08/19/22
$XBI $87.27 | -1.8% Table of Contents: Top 10 Daily Positive Movers Top 10 Daily Negative Movers Top 10 Daily Volume Movers Want to get...
Aug 19, 20221 min read


Free Biopharma Daily Pulse - 08/19/22
$XBI $87.27 | -1.8% Table of Contents: Top 10 Daily Positive Movers Top 10 Daily Negative Movers Top 10 Daily Volume Movers Want to get...
Aug 19, 20221 min read


Biopharma Pulse - 6/27-7/1 Week in Review
As we reach the end of June, we review moves from smid-cap biopharma companies during this past week. See Table 1 for weekly moves and...
Jul 1, 20222 min read


Biopharma Daily Stock Updates - 06/27/22
$XBI $76.80 | -0.34% Table of Contents: Pipeline Updates Business Updates Covid Updates #BNTX +7.2% Pfizer and BioNTech Announce...
Jun 27, 20222 min read


Free Biopharma Daily Stock Updates - 06/27/22
$XBI $76.80 | -0.34% Table of Contents: Pipeline Updates Business Updates Covid Updates #BNTX +7.2% Pfizer and BioNTech Announce...
Jun 27, 20222 min read


Biopharma Daily Stock Updates - 06/22/22
$XBI $71.79 | +2.51% Table of Contents: Covid Updates Pipeline Updates Business Updates Covid Updates #MDNA +14.4% Moderna Announces...
Jun 22, 20222 min read


Free Biopharma Daily Stock Updates - 06/22/22
$XBI $71.79 | +2.51% Table of Contents: Covid Updates Pipeline Updates Business Updates Covid Updates #MDNA +14.4% Moderna Announces...
Jun 22, 20222 min read


Biopharma Daily Stock Updates - 06/02/22
$XBI $68.77 | +1.84% Table of Contents: Covid Updates Pipeline Updates Business Updates Covid Updates #MRNA -2.3% Moderna and the...
Jun 2, 20222 min read


Free Biopharma Daily Stock Updates - 06/02/22
$XBI $68.77 | +1.84% Table of Contents: Covid Updates Pipeline Updates Business Updates Covid Updates #MRNA -2.3% Moderna and the...
Jun 2, 20222 min read


Biopharma Daily Stock Updates - 06/01/22
$XBI $67.53 | -1.8% Table of Contents: Covid Updates Pipeline Updates Business Updates Covid Updates #COCP +2.7% Cocrystal Pharma...
Jun 1, 20223 min read


Free Biopharma Daily Stock Updates - 06/01/22
$XBI $67.53 | -1.8% Table of Contents: Covid Updates Pipeline Updates Business Updates Covid Updates #COCP +2.7% Cocrystal Pharma...
Jun 1, 20223 min read


Biopharma Daily Pulse - 05/31/22 (Subscribers)
$XBI $68.78 | -3.25% BPIQ median | -1.84% Big Positive Movers on News #TXMD +364% TherapeuticsMD and EW Healthcare Partners Announce...
May 31, 20222 min read


Biopharma Daily Pulse - 05/31/22 (Free Blog)
$XBI $68.78 | -3.25% BPIQ median | -1.84% Big Positive Movers on News #TXMD +364% TherapeuticsMD and EW Healthcare Partners Announce...
May 31, 20222 min read
Jump start your biotech due diligence
Our platform helps you uncover your next biotech investment opportunity
bottom of page
